In fact, the inhibition of PARP14 using inhibitor PJ34 made MM and HCC cells much more sensitive to anti-MM or anti-HCC drugs (Barbarulo et al., 2013; Iansante et al., 2015). Here, PARP14 is linked to Miyoshi myopathy.